Bruce E Hillner

Summary

Affiliation: Virginia Commonwealth University
Country: USA

Publications

  1. ncbi request reprint The National Oncologic PET Registry (NOPR): design and analysis plan
    Bruce E Hillner
    Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298 0170, USA
    J Nucl Med 48:1901-8. 2007
  2. ncbi request reprint Costs of care associated with non-small-cell lung cancer in a commercially insured cohort
    B E Hillner
    Department of Internal Medicine, Medical College of Virginia and Massey Cancer Center, Virginia Commonwealth University, Richmond 23298 0170, USA
    J Clin Oncol 16:1420-4. 1998
  3. ncbi request reprint Trends in clinical trials reports in common cancers between 1989 and 2000
    Bruce E Hillner
    Department of Internal Medicine, the Outcomes Research Institute, and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298 0170, USA
    J Clin Oncol 21:1850-8. 2003
  4. ncbi request reprint Is cancer care best at high-volume providers?
    B E Hillner
    Massey Cancer Center, Department of Internal Medicine, Medical College of Virginia at Virginia Commonwealth University, Box 980170, Richmond, VA 23298 0170, USA
    Curr Oncol Rep 3:404-9. 2001
  5. ncbi request reprint Burden of illness associated with metastatic melanoma: an audit of 100 consecutive referral center cases
    B E Hillner
    Department of Internal Medicine and the Massey Cancer Center, Medical College of Virginia Campus at Virginia Commonwealth University, Richmond, Virginia 23298 0170, USA
    Cancer 91:1814-21. 2001
  6. ncbi request reprint Cost-effectiveness analysis of exemestane compared with megestrol in patients with advanced breast carcinoma
    B E Hillner
    Department of Internal Medicine, Virginia Commonwealth University and the Massey Cancer Center, Richmond, VA 23298 0170, USA
    Cancer 91:484-9. 2001
  7. ncbi request reprint The role of bisphosphonates in metastatic breast cancer
    B E Hillner
    Department of Internal Medicine, Virginia Commonwealth University, and the Massey Cancer Center, Richmond, VA 23298 0170, USA
    Semin Radiat Oncol 10:250-3. 2000
  8. ncbi request reprint Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care
    B E Hillner
    Massey Cancer Center and Department of Internal Medicine, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA 23298 0170, USA
    J Clin Oncol 18:2327-40. 2000
  9. ncbi request reprint Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanoma
    B E Hillner
    Department of Internal Medicine and the Massey Cancer Center, Medical College of Virginia Campus at Virginia Commonwealth University, Richmond, VA 23298 0170, USA
    J Clin Oncol 18:1474-80. 2000
  10. ncbi request reprint Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis
    B E Hillner
    Department of Internal Medicine, Virginia Commonwealth University and the Massey Cancer Center, Richmond, VA, USA
    J Clin Oncol 18:72-9. 2000

Detail Information

Publications37

  1. ncbi request reprint The National Oncologic PET Registry (NOPR): design and analysis plan
    Bruce E Hillner
    Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298 0170, USA
    J Nucl Med 48:1901-8. 2007
    ..The NOPR opened in May 2006. This report reviews the NOPR's data collection and analysis plan...
  2. ncbi request reprint Costs of care associated with non-small-cell lung cancer in a commercially insured cohort
    B E Hillner
    Department of Internal Medicine, Medical College of Virginia and Massey Cancer Center, Virginia Commonwealth University, Richmond 23298 0170, USA
    J Clin Oncol 16:1420-4. 1998
    ..To examine the cost of incident cases of non-small-cell lung cancer (NSCLC) in a commercially insured cohort...
  3. ncbi request reprint Trends in clinical trials reports in common cancers between 1989 and 2000
    Bruce E Hillner
    Department of Internal Medicine, the Outcomes Research Institute, and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298 0170, USA
    J Clin Oncol 21:1850-8. 2003
    ..This exploratory study sought to describe the epidemiologic patterns of clinical trial reports in common cancers...
  4. ncbi request reprint Is cancer care best at high-volume providers?
    B E Hillner
    Massey Cancer Center, Department of Internal Medicine, Medical College of Virginia at Virginia Commonwealth University, Box 980170, Richmond, VA 23298 0170, USA
    Curr Oncol Rep 3:404-9. 2001
    ..Care is better at high-volume providers for a select minority of cancers. Whether provider volume matters in the majority of cancers at the time of presentation has not been evaluated...
  5. ncbi request reprint Burden of illness associated with metastatic melanoma: an audit of 100 consecutive referral center cases
    B E Hillner
    Department of Internal Medicine and the Massey Cancer Center, Medical College of Virginia Campus at Virginia Commonwealth University, Richmond, Virginia 23298 0170, USA
    Cancer 91:1814-21. 2001
    ..Because different patterns of care of MM are likely to vary substantially in their intensity and resource use, the authors audited care at a regional referral center...
  6. ncbi request reprint Cost-effectiveness analysis of exemestane compared with megestrol in patients with advanced breast carcinoma
    B E Hillner
    Department of Internal Medicine, Virginia Commonwealth University and the Massey Cancer Center, Richmond, VA 23298 0170, USA
    Cancer 91:484-9. 2001
    ....
  7. ncbi request reprint The role of bisphosphonates in metastatic breast cancer
    B E Hillner
    Department of Internal Medicine, Virginia Commonwealth University, and the Massey Cancer Center, Richmond, VA 23298 0170, USA
    Semin Radiat Oncol 10:250-3. 2000
    ....
  8. ncbi request reprint Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care
    B E Hillner
    Massey Cancer Center and Department of Internal Medicine, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA 23298 0170, USA
    J Clin Oncol 18:2327-40. 2000
    ..To conduct a comprehensive review of the health services literature to search for evidence that hospital or physician volume or specialty affects the outcome of cancer care...
  9. ncbi request reprint Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanoma
    B E Hillner
    Department of Internal Medicine and the Massey Cancer Center, Medical College of Virginia Campus at Virginia Commonwealth University, Richmond, VA 23298 0170, USA
    J Clin Oncol 18:1474-80. 2000
    ..To determine the potential economic implications resulting from oral temozolomide (TEM) compared with intravenous (IV) dacarbazine (DTIC) for metastatic melanoma...
  10. ncbi request reprint Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis
    B E Hillner
    Department of Internal Medicine, Virginia Commonwealth University and the Massey Cancer Center, Richmond, VA, USA
    J Clin Oncol 18:72-9. 2000
    ..We conducted a post-hoc evaluation of the cost-effectiveness of pamidronate using the results of two randomized trials that evaluated pamidronate 90 mg administered intravenously every month versus placebo...
  11. doi request reprint Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry
    Bruce E Hillner
    Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, 1101 E Marshall St, Room 7013, Richmond, VA 23298 0170, USA
    J Clin Oncol 26:2155-61. 2008
    ..The National Oncologic PET Registry (NOPR) was developed to meet these coverage requirements and to assess how PET affects care decisions...
  12. doi request reprint The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry
    Bruce E Hillner
    Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298 0170, USA
    Cancer 115:410-8. 2009
    ..Under the Medicare 'coverage with evidence development' policy, PET (and integrated PET/computed tomography) became a covered service for treatment monitoring if prospective registry data were collected...
  13. doi request reprint Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry
    Bruce E Hillner
    Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA
    J Nucl Med 49:1928-35. 2008
    ..Here, we present results for specific cancer types and indications for testing...
  14. doi request reprint Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts
    Bruce E Hillner
    Department of Internal Medicine and Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298 0170, USA
    J Nucl Med 53:831-7. 2012
    ....
  15. pmc Intended versus inferred management after PET for cancer restaging: analysis of Medicare claims linked to a coverage with evidence development registry
    Bruce E Hillner
    Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA
    Med Care 51:361-7. 2013
    ....
  16. pmc Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement?
    Bruce E Hillner
    Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298, USA
    J Am Coll Radiol 9:33-41. 2012
    ..Whether physicians use PET as a replacement for or in addition to CT, MRI, or bone scintigraphy (BS) is uncertain...
  17. pmc Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET Registry
    Bruce E Hillner
    Department of Internal Medicine, Virginia Commonwealth University, 1101 E Marshall St Room 7013, Richmond, VA 23298 0170, USA
    Mol Imaging Biol 13:161-5. 2011
    ..This study seeks to assess the impact of dedicated brain positron emission tomography (PET) with 2-deoxy-2-[(18)F]fluoro-D-glucose on intended management of patients with primary and metastatic brain tumors...
  18. doi request reprint Concrete options and ideas for increasing value in oncology care: the view from one trench
    Thomas J Smith
    Massey Cancer Center, Virginia Commonwealth University Health System, Richmond, Virginia, USA
    Oncologist 15:65-72. 2010
    ..These actions will likely control costs, but in the short term will cause significant distress among patients, families, and health care practitioners...
  19. ncbi request reprint Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma
    Bruce E Hillner
    Department of Internal Medicine and Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298, USA
    Cancer 104:1871-84. 2005
    ..The trade-offs between costs and survival for these two regimens have not been explored...
  20. ncbi request reprint A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids
    Lenore M Buckley
    Virginia Commonwealth University, Richmond 23298, USA
    J Rheumatol 30:132-8. 2003
    ....
  21. ncbi request reprint Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer
    Bruce E Hillner
    Department of Internal Medicine, Virginia Commonwealth University, Richmond 23298, USA
    Cancer 101:1311-22. 2004
    ....
  22. doi request reprint Allocating cancer-directed expenditures: tensions between prevention, early detection and treatment is unnecessary
    Bruce E Hillner
    Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298 0170, USA
    Recent Results Cancer Res 188:1-9. 2011
    ..Changing behaviors, incentives, expectations, and the framing of treatment effects are necessary to "bend" the current unrelenting cancer care cost curve...
  23. doi request reprint Explaining marginal benefits to patients, when "marginal" means additional but not necessarily small
    Thomas J Smith
    Division of Hematology Oncology, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA
    Clin Cancer Res 16:5981-6. 2010
    ..These difficult conversations can be done if the oncologist has the right medical information, the right script, and some decision aids...
  24. ncbi request reprint Clinical decisions associated with positron emission tomography in a prospective cohort of patients with suspected or known cancer at one United States center
    Bruce E Hillner
    Division of General Medicine, Virginia Commonwealth University, 1101 E Marshall St, Sanger Hall, Room 7 083, Richmond, VA 23298, USA
    J Clin Oncol 22:4147-56. 2004
    ..PET has been observed to be more accurate than other imaging in cancer patients, but the impact of PET on management in routine practice is uncertain...
  25. ncbi request reprint Diagnosis of lower-extremity deep vein thrombosis in outpatients with musculoskeletal disorders: a national survey study of physical therapists
    Daniel L Riddle
    Department of Physical Therapy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298 0224, USA
    Phys Ther 84:717-28. 2004
    ....
  26. doi request reprint A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis
    Jill K J Gaidos
    Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, VA, USA
    Liver Int 28:650-8. 2008
    ..Liver biopsy (LB) is the only way to determine the severity of disease. However, LB is invasive, has complications and financial costs. The aim of this study is to determine the benefits of early LB for diagnosis and early treatment...
  27. ncbi request reprint NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer
    Donald A Podoloff
    J Natl Compr Canc Netw 5:S1-22; quiz S23-2. 2007
    ..This report summarizes the proceedings of this meeting, including discussions of the background of PET, possible future developments, and the role of PET in oncology...
  28. ncbi request reprint Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer
    Richard R Love
    University of Wisconsin Comprehensive Cancer Center, 610 Walnut Street, Madison, WI 53705 2397, USA
    J Clin Oncol 20:2559-66. 2002
    ..Approximately 350,000 new cases of breast cancer are diagnosed annually in premenopausal Asian women who have lower levels of estrogen than western women...
  29. ncbi request reprint Barriers to clinical trial enrollment: are state mandates the solution?
    Bruce E Hillner
    J Natl Cancer Inst 96:1048-9. 2004
  30. ncbi request reprint Caring for older women with breast cancer: can observational research fill the clinical trial gap?
    Bruce E Hillner
    J Natl Cancer Inst 98:660-1. 2006
  31. ncbi request reprint Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?
    Bruce E Hillner
    J Clin Oncol 25:611-3. 2007
  32. ncbi request reprint The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development
    Matthew J Lindsay
    Foley Hoag, LLP, 155 Seaport Blvd, Boston, MA 02210 2600, USA
    AJR Am J Roentgenol 188:1109-13. 2007
    ....
  33. ncbi request reprint American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer
    Bruce E Hillner
    J Clin Oncol 21:4042-57. 2003
    ..To update the 2000 ASCO guidelines on the role of bisphosphonates in women with breast cancer and address the subject of bone health in these women...
  34. ncbi request reprint Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast
    W Warren Suh
    Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, MI, USA
    Int J Radiat Oncol Biol Phys 61:1054-61. 2005
    ..To assess the cost-effectiveness of radiation therapy (RT) in patients with ductal carcinoma in situ (DCIS) after breast-conserving surgery (BCS)...
  35. ncbi request reprint Genomics-based prognosis and therapeutic prediction in breast cancer
    Stefanie S Jeffrey
    Department of Surgery, Stanford University School of Medicine, Stanford, California, 94305 5494, USA
    J Natl Compr Canc Netw 3:291-300. 2005
    ..We believe that the characterization and discernment of different systems among breast cancers is crucial for understanding drug sensitivity and resistance mechanisms and for guiding therapy...
  36. ncbi request reprint Taking action on the volume-quality relationship: how long can we hide our heads in the colostomy bag?
    Thomas J Smith
    J Natl Cancer Inst 95:695-7. 2003
  37. ncbi request reprint Do cancer centers designated by the National Cancer Institute have better surgical outcomes?
    Nancy J O Birkmeyer
    Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan, USA
    Cancer 103:435-41. 2005
    ..In the current study, the authors assessed whether patients at NCI cancer centers compared with patients at control hospitals had lower mortality rates after major cancer surgery...